IMU (ASX) l c interview

Originally posted by supertramp: ↑

The thing is... the phase 1b results when first announced (although light on detail) were pretty dam good.

9/10 ten responders, with no safety issues at all - for these very ill patients with a nasty metastasized cancer.

5 of which were partial responses, but as I said the other day, one can see a reduction of 95% of their cancer and still be classed as a partial response. Partial being anywhere between greater than 30% and less than 100% (in imu's case).

But the average asx investor doesn't seem to understand how good these figures are (as opposed to the UK and US for example). But maybe it's because in Australia investors haven't seen a massive biotech win, like we have in the UK and US.

So on good news the sp drifted from 2.1c down to 1.6c.

Even some well informed investors like Money Mozart sold out on the news.

But now the data will be presented to the world, big pharma and maybe the press. There will also be more details and more data given. As we now have a complete responder and another greater than 30% responder, it appears as though the patients are still getting better. That's massive, especially as still being alive is a bonus for these seriously ill cancer patients. And still no safety issues.

Being selected for presentation is a big deal. Viralytics were too, and look what happened to them (taken over by Merck for over $50om).

But imu's technology and platform is so much bigger and more significant than Viralytics was/is (no offense to Viralytics, and I was a shareholder of them too).

Viralytics offered an improvement on two T cell therapy, Imugene offer a completely new and safer generation to all T cell therapies.

cheers

Expand

supertramp: "...Imugene offer a completely new and safer generation to all T cell therapies."

SUPER conclusion of a SUPER POST by you !!! MANY THANKS.

wasa

PS: I continue to be astonished at how low a valuation IMU is still trading...

No.	Vol.	Price($)
11	949810	3.7¢

No.

Vol.

Price($)

949810

3.7¢

Price($)	Vol.	No.
3.8¢	2277658	11

Price($)

Vol.

No.

3.8¢

2277658

No.	Vol.	Price($)
18	5665336	0.018
14	3997559	0.017
6	2974375	0.016
10	3219799	0.015
4	497500	0.014

No.

Vol.

Price($)

5665336

0.018

3997559

0.017

2974375

0.016

3219799

0.015

497500

0.014

Price($)	Vol.	No.
0.019	400000	2
0.020	5410946	12
0.021	8494780	17
0.022	8757253	13
0.023	4826614	8

Price($)

Vol.

No.

0.019

400000

0.020

5410946

0.021

8494780

0.022

8757253

0.023

4826614

(20min delay)
Last 3.8¢		Change 0.000(0.00%)		Mkt cap ! $386.7M

Open	High	Low	Value	Volume
3.8¢	3.8¢	3.7¢	$270.7K	7.251M

l c interview, page-42

Buyers (Bids)

Sellers (Offers)